Who is sponsoring NCT02627495?

NCT02627495 is sponsored by Spaulding Rehabilitation Hospital.

What drugs are being tested in NCT02627495?

Interventions in NCT02627495: transcranial Direct Current Stimulation (tDCS): (Soterix ©).

What condition does NCT02627495 study?

NCT02627495 studies Phantom Limb Pain.

Is NCT02627495 still recruiting?

NCT02627495 is currently completed. Last updated 11 May 2021.

Are results published for NCT02627495?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2021-05-11 · How we verify

NCT02627495

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Predicting Pain Response to Transcranial Direct Current Stimulation for Phantom Limb Pain in Limb Amputees

Completed Results posted Last updated 11 May 2021

What this trial tests

trial testing transcranial Direct Current Stimulation (tDCS): (Soterix ©) in Phantom Limb Pain in 9 participants. Completed in 9 March 2021.

Timeline

1 December 2015

Primary endpoint
22 November 2019

9 March 2021

Quick facts

Lead sponsor	Spaulding Rehabilitation Hospital
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	9
Start date	1 December 2015
Primary completion	22 November 2019
Estimated completion	9 March 2021
Sites	1 location across United States

Drugs / interventions tested

transcranial Direct Current Stimulation (tDCS): (Soterix ©)

Conditions studied

Phantom Limb Pain — all drugs for Phantom Limb Pain →

Sponsor

Spaulding Rehabilitation Hospital

Who can join

18 and older, any sex, with Phantom Limb Pain. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Pain as Measured by the Visual Analog Scale Primary · Change in outcome from baseline to 2-week follow-up (after the last day of stimulation)

The VAS is a common assessment used which asks subjects to self-reportedly measure their pain on a visual scale (i.e., unbearable to none). We will use a VAS to determine subjects' pain scores. Subjects will rate their pain from 0 - indicating no pain at all, to 10 - indicating the worst pain felt. This scale is also colored, from green (at 0) to red (at 10), as a visual indicator of pain.

Group	Value	95% CI
tDCS Intervention (Open Label)	-1.4	± 1.14

Sponsor's own description

This study explores the effects transcranial Direct Current Stimulation (tDCS, Soterix ©) on Phantom Limb Pain for patients experiencing chronic phantom limb pain in open-label study design.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Phantom Limb Pain

Currently open trials in the same condition.

NCT07401966 — Amputations in Childhood and Neuropathic Pain · recruiting
NCT06719245 — Prevention of PostAmputation Pain With Targeted Muscle Reinnervation · NA · recruiting
NCT06702904 — Evaluation of Neuroprosthesis with Sensory Feedback for Modulation of Phantom Limb Pain and Enhancing Quality of Life · NA · recruiting
NCT06813937 — Peripheral Magnetic Stimulation (PMS) Effects on Somatosensory Perception in Patients with Upper Limb Amputation · NA · recruiting
NCT06644807 — Study of Phantom Limb Pain Suppression Using Neuromodulation Methods · NA · recruiting

Other Spaulding Rehabilitation Hospital trials

Trials by the same sponsor.

NCT04940403 — BurtVision™ for Arm Rehabilitation in Chronic Stroke Survivors: · NA · not yet recruiting
NCT06193317 — Effects of taVNS on Fibromyalgia Pain · NA · not yet recruiting
NCT07483320 — Extracorporeal Shockwave Therapy and Platelet-Rich Plasma for Midportion Achilles Tendinopathy · NA · not yet recruiting
NCT06797154 — A Novel Wrist Wearable Sensor System to Promote Hemiparetic Upper Extremity Use in Subacute Stroke Survivors · NA · recruiting
NCT06826781 — Evaluating Q-Collar Effects on Brain Blood Flow Control During Exercise · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02627495 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Spaulding Rehabilitation Hospital
Last refreshed: 11 May 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02627495.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing